1. Home
  2. FNWB vs CTMX Comparison

FNWB vs CTMX Comparison

Compare FNWB & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$9.73

Market Cap

87.9M

Sector

Finance

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.37

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
CTMX
Founded
1923
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.9M
596.2M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
FNWB
CTMX
Price
$9.73
$4.37
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$13.50
$6.50
AVG Volume (30 Days)
33.9K
2.9M
Earning Date
01-28-2026
11-06-2025
Dividend Yield
1.44%
N/A
EPS Growth
N/A
50.22
EPS
N/A
0.24
Revenue
$54,052,000.00
$113,631,000.00
Revenue This Year
$31.86
N/A
Revenue Next Year
$10.64
N/A
P/E Ratio
N/A
$17.53
Revenue Growth
6.47
N/A
52 Week Low
$6.05
$0.40
52 Week High
$12.10
$4.62

Technical Indicators

Market Signals
Indicator
FNWB
CTMX
Relative Strength Index (RSI) 52.19 61.63
Support Level $9.88 $3.86
Resistance Level $10.08 $4.37
Average True Range (ATR) 0.14 0.25
MACD -0.07 0.01
Stochastic Oscillator 6.25 91.85

Price Performance

Historical Comparison
FNWB
CTMX

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: